TreeWAS – Variant ID: rs8756

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
E11.9 Without complications	0.955	0.045	0.000
E11 Non-insulin-dependent diabetes mellitus	0.878	0.122	0.000
E11.3 With ophthalmic complications	0.864	0.136	0.000
E11.8 With unspecified complications	0.772	0.228	0.000
E11.6 With other specified complications	0.763	0.237	0.000
E11.1 With ketoacidosis	0.688	0.312	0.000
E11.7 With multiple complications	0.629	0.370	0.000
E11.0 With coma	0.624	0.376	0.000
E11.2 With renal complications	0.519	0.481	0.000
E11.5 With peripheral circulatory complications	0.336	0.664	0.000
E11.4 With neurological complications	0.205	0.795	0.000
E10-E14 Diabetes mellitus	0.129	0.871	0.000
C43 Malignant melanoma of skin	0.000	0.903	0.097
C43.7 Malignant melanoma of lower limb, including hip	0.000	0.904	0.096
C43.5 Malignant melanoma of trunk	0.000	0.905	0.095
E12 Malnutrition-related diabetes mellitus	0.092	0.908	0.000
C43.9 Malignant melanoma of skin, unspecified	0.000	0.909	0.091
C43.4 Malignant melanoma of scalp and neck	0.000	0.910	0.090
C43.6 Malignant melanoma of upper limb, including shoulder	0.000	0.913	0.087
E14 Unspecified diabetes mellitus	0.077	0.923	0.000
E13 Other specified diabetes mellitus	0.074	0.926	0.000
C43.8 Overlapping malignant melanoma of skin	0.000	0.930	0.070
C43.0 Malignant melanoma of lip	0.000	0.930	0.070
E12.9 Without complications	0.066	0.933	0.000
E12.8 With unspecified complications	0.066	0.933	0.000
E12.7 With multiple complications	0.066	0.933	0.000
E12.6 With other specified complications	0.066	0.933	0.000
E12.5 With peripheral circulatory complications	0.066	0.933	0.000
E12.4 With neurological complications	0.066	0.933	0.000
E12.3 With ophthalmic complications	0.066	0.933	0.000
E12.2 With renal complications	0.066	0.933	0.000
E12.1 With ketoacidosis	0.066	0.933	0.000
E12.0 With coma	0.066	0.933	0.000
E14.2 Withrenal complications	0.065	0.934	0.000
E14.9 Without complications	0.063	0.937	0.000
E14.1 With ketoacidosis	0.059	0.941	0.000
C43.2 Malignant melanoma of ear and external auricular canal	0.000	0.942	0.057
C43.1 Malignant melanoma of eyelid, including canthus	0.000	0.943	0.057
E14.8 With unspecified complications	0.056	0.943	0.000
E13.3 With ophthalmic complications	0.056	0.944	0.000
E14.7 With multiple complications	0.056	0.944	0.000
E14.0 With coma	0.056	0.944	0.000
E13.8 With unspecified complications	0.053	0.946	0.000
E13.7 With multiple complications	0.053	0.946	0.000
E13.6 With other specified complications	0.053	0.946	0.000
E13.5 With peripheral circulatory complications	0.053	0.946	0.000
E13.4 With neurological complications	0.053	0.946	0.000
E13.2 With renal complications	0.053	0.946	0.000
E13.1 With ketoacidosis	0.053	0.946	0.000
E13.0 With coma	0.053	0.946	0.000
E14.4 With neurological complications	0.052	0.948	0.000
E14.6 With other specified complications	0.050	0.949	0.000
E10 Insulin-dependent diabetes mellitus	0.047	0.953	0.000
E10.6 With other specified complications	0.039	0.960	0.000
E14.5 With peripheral circulatory complications	0.038	0.961	0.000
E10.0 With coma	0.038	0.962	0.000
C43.3 Malignant melanoma of other and unspecified parts of face	0.000	0.962	0.038
E10.1 With ketoacidosis	0.037	0.963	0.000
N36.8 Other specified disorders of urethra	0.000	0.965	0.035
N36.2 Urethral caruncle	0.000	0.966	0.034
E10.3 With ophthalmic complications	0.034	0.966	0.000
E10.8 With unspecified complications	0.033	0.967	0.000
E10.7 With multiple complications	0.033	0.967	0.000
I89.0 Lymphoedema, not elsewhere classified	0.032	0.968	0.000
N36 Other disorders of urethra	0.000	0.969	0.031
E04.2 Non-toxic multinodular goitre	0.031	0.969	0.000
E13.9 Without complications	0.030	0.970	0.000
E10.2 With renal complications	0.029	0.971	0.000
E14.3 With ophthalmic complications	0.029	0.971	0.000
N36.1 Urethral diverticulum	0.000	0.974	0.026
I89 Other non-infective disorders of lymphatic vessels and lymph nodes	0.026	0.974	0.000
I89.8 Other specified non-infective disorders of lymphatic vessels and lymph nodes	0.024	0.976	0.000
N36.3 Prolapsed urethral mucosa	0.000	0.977	0.023
I89.1 Lymphangitis	0.021	0.978	0.000
N36.9 Urethral disorder, unspecified	0.000	0.979	0.021
E10.9 Without complications	0.021	0.979	0.000
E10.5 With peripheral circulatory complications	0.019	0.980	0.000
I89.9 Non-infective disorder of lymphatic vessels and lymph nodes, unspecified	0.019	0.981	0.000
E10.4 With neurological complications	0.017	0.983	0.000
C43-C44 Melanoma and other malignant neoplasms of skin	0.000	0.983	0.017
E61.1 Iron deficiency	0.015	0.985	0.000
Chapter IV Endocrine, nutritional and metabolic diseases	0.015	0.985	0.000
E04 Other non-toxic goitre	0.014	0.986	0.000
E61 Deficiency of other nutrient elements	0.014	0.986	0.000
E50-E64 Other nutritional deficiencies	0.014	0.986	0.000
N36.0 Urethral fistula	0.000	0.987	0.013
E00-E07 Disorders of thyroid gland	0.012	0.988	0.000
M06.97 Rheumatoid arthritis, unspecified (Ankle and foot)	0.000	0.989	0.011
E58 Dietary calcium deficiency	0.011	0.989	0.000
E04.0 Non-toxic diffuse goitre	0.011	0.989	0.000
E04.8 Other specified non-toxic goitre	0.010	0.989	0.000
E56 Other vitamin deficiencies	0.010	0.990	0.000
E51 Thiamine deficiency	0.010	0.990	0.000
E61.9 Deficiency of nutrient element, unspecified	0.010	0.990	0.000
E61.8 Deficiency of other specified nutrient elements	0.010	0.990	0.000
E61.7 Deficiency of multiple nutrient elements	0.010	0.990	0.000
E61.6 Vanadium deficiency	0.010	0.990	0.000
E61.5 Molybdenum deficiency	0.010	0.990	0.000
E61.4 Chromium deficiency	0.010	0.990	0.000
E61.3 Manganese deficiency	0.010	0.990	0.000
E61.0 Copper deficiency	0.010	0.990	0.000
E54 Ascorbic acid deficiency	0.010	0.990	0.000
E40-E46 Malnutrition	0.010	0.990	0.000
M06.00 Seronegative rheumatoid arthritis (Multiple sites)	0.000	0.990	0.010
E64 Sequelae of malnutrition and other nutritional deficiencies	0.010	0.990	0.000
E63 Other nutritional deficiencies	0.010	0.990	0.000
E50 Vitamin A deficiency	0.010	0.990	0.000
E60 Dietary zinc deficiency	0.010	0.990	0.000
E59 Dietary selenium deficiency	0.010	0.990	0.000
E52 Niacin deficiency [pellagra]	0.010	0.990	0.000
D75.2 Essential thrombocytosis	0.010	0.990	0.000
M06.90 Rheumatoid arthritis, unspecified (Multiple sites)	0.000	0.990	0.010
M06.9 Rheumatoid arthritis, unspecified	0.000	0.990	0.010
E61.2 Magnesium deficiency	0.009	0.990	0.000
J61 Pneumoconiosis due to asbestos and other mineral fibres	0.009	0.990	0.000
E02 Subclinical iodine-deficiency hypothyroidism	0.009	0.991	0.000
M06.96 Rheumatoid arthritis, unspecified (Lower leg)	0.000	0.991	0.009
M06.0 Seronegative rheumatoid arthritis	0.000	0.991	0.009
E01 Iodine-deficiency-related thyroid disorders and allied conditions	0.009	0.991	0.000
E00 Congenital iodine-deficiency syndrome	0.009	0.991	0.000
E06 Thyroiditis	0.009	0.991	0.000
M06 Other rheumatoid arthritis	0.000	0.991	0.008
J38.0 Paralysis of vocal cords and larynx	0.000	0.992	0.008
M06.99 Rheumatoid arthritis, unspecified (Site unspecified)	0.000	0.992	0.008
E53 Deficiency of other B group vitamins	0.008	0.992	0.000
E04.9 Non-toxic goitre, unspecified	0.008	0.992	0.000
I62.0 Subdural haemorrhage (acute) (nontraumatic)	0.000	0.992	0.008
E56.1 Deficiency of vitamin K	0.008	0.992	0.000
E15-E16 Other disorders of glucose regulation and pancreatic internal secretion	0.008	0.992	0.000
E51.2 Wernicke's encephalopathy	0.008	0.992	0.000
T51.9 Alcohol, unspecified	0.008	0.992	0.000
E56.9 Vitamin deficiency, unspecified	0.007	0.992	0.000
E56.8 Deficiency of other vitamins	0.007	0.992	0.000
E56.0 Deficiency of vitamin E	0.007	0.992	0.000
E51.9 Thiamine deficiency, unspecified	0.007	0.992	0.000
E51.8 Other manifestations of thiamine deficiency	0.007	0.992	0.000
E51.1 Beriberi	0.007	0.992	0.000
M06.4 Inflammatory polyarthropathy	0.000	0.992	0.008
E44 Protein-energy malnutrition of moderate and mild degree	0.007	0.992	0.000
E45 Retarded development following protein-energy malnutrition	0.007	0.992	0.000
E43 Unspecified severe protein-energy malnutrition	0.007	0.992	0.000
E42 Marasmic kwashiorkor	0.007	0.992	0.000
E41 Nutritional marasmus	0.007	0.992	0.000
E40 Kwashiorkor	0.007	0.992	0.000
E20-E35 Disorders of other endocrine glands	0.008	0.992	0.000
E50.9 Vitamin A deficiency, unspecified	0.007	0.992	0.000
E50.8 Other manifestations of vitamin A deficiency	0.007	0.992	0.000
E50.7 Other ocular manifestations of vitamin A deficiency	0.007	0.992	0.000
E50.6 Vitamin A deficiency with xerophthalmic scars of cornea	0.007	0.992	0.000
E50.5 Vitamin A deficiency with night blindness	0.007	0.992	0.000
E50.4 Vitamin A deficiency with keratomalacia	0.007	0.992	0.000
E50.3 Vitamin A deficiency with corneal ulceration and xerosis	0.007	0.992	0.000
E50.2 Vitamin A deficiency with corneal xerosis	0.007	0.992	0.000
E50.1 Vitamin A deficiency with Bitot's spot and conjunctival xerosis	0.007	0.992	0.000
E50.0 Vitamin A deficiency with conjunctival xerosis	0.007	0.992	0.000
E63.9 Nutritional deficiency, unspecified	0.007	0.992	0.000
E63.8 Other specified nutritional deficiencies	0.007	0.992	0.000
E63.1 Imbalance of constituents of food intake	0.007	0.992	0.000
E63.0 Essential fatty acid [EFA] deficiency	0.007	0.992	0.000
E64.9 Sequelae of unspecified nutritional deficiency	0.007	0.992	0.000
E64.8 Sequelae of other nutritional deficiencies	0.007	0.992	0.000
E64.3 Sequelae of rickets	0.007	0.992	0.000
E64.2 Sequelae of vitamin C deficiency	0.007	0.992	0.000
E64.1 Sequelae of vitamin A deficiency	0.007	0.992	0.000
E64.0 Sequelae of protein-energy malnutrition	0.007	0.992	0.000
M06.06 Seronegative rheumatoid arthritis (Lower leg)	0.000	0.993	0.007
K80.4 Calculus of bile duct with cholecystitis	0.007	0.993	0.000
R82.9 Other and unspecified abnormal finding in urine	0.007	0.993	0.000
M06.49 Inflammatory polyarthropathy (Site unspecified)	0.000	0.993	0.007
M06.09 Seronegative rheumatoid arthritis (Site unspecified)	0.000	0.993	0.007
M06.92 Rheumatoid arthritis, unspecified (Upper arm)	0.000	0.993	0.007
E55 Vitamin D deficiency	0.007	0.993	0.000
M06.05 Seronegative rheumatoid arthritis (Pelvic region and thigh)	0.000	0.993	0.007
E46 Unspecified protein-energy malnutrition	0.007	0.993	0.000
M06.08 Seronegative rheumatoid arthritis (Other)	0.000	0.993	0.007
M06.03 Seronegative rheumatoid arthritis (Forearm)	0.000	0.993	0.007
M06.02 Seronegative rheumatoid arthritis (Upper arm)	0.000	0.993	0.007
E00.9 Congenital iodine-deficiency syndrome, unspecified	0.007	0.993	0.000
E00.2 Congenital iodine-deficiency syndrome, mixed type	0.007	0.993	0.000
E00.1 Congenital iodine-deficiency syndrome, myxoedematous type	0.007	0.993	0.000
E00.0 Congenital iodine-deficiency syndrome, neurological type	0.007	0.993	0.000
E01.8 Other iodine-deficiency-related thyroid disorders and allied conditions	0.007	0.993	0.000
E01.2 Iodine-deficiency-related (endemic) goitre, unspecified	0.007	0.993	0.000
E01.1 Iodine-deficiency-related multinodular (endemic) goitre	0.007	0.993	0.000
E01.0 Iodine-deficiency-related diffuse (endemic) goitre	0.007	0.993	0.000
E06.1 Subacute thyroiditis	0.007	0.993	0.000
R82.8 Abnormal findings on cytological and histological examination of urine	0.007	0.993	0.000
M06.95 Rheumatoid arthritis, unspecified (Pelvic region and thigh)	0.000	0.993	0.007
E06.5 Other chronic thyroiditis	0.007	0.993	0.000
R82 Other abnormal findings in urine	0.007	0.993	0.000
E06.4 Drug-induced thyroiditis	0.006	0.993	0.000
E06.2 Chronic thyroiditis with transient thyrotoxicosis	0.006	0.993	0.000
E06.0 Acute thyroiditis	0.006	0.993	0.000
E06.9 Thyroiditis, unspecified	0.007	0.993	0.000
R82.4 Acetonuria	0.007	0.993	0.000
E20 Hypoparathyroidism	0.006	0.993	0.000
M06.07 Seronegative rheumatoid arthritis (Ankle and foot)	0.000	0.994	0.006
M06.04 Seronegative rheumatoid arthritis (Hand)	0.000	0.994	0.006
E34 Other endocrine disorders	0.006	0.994	0.000
M06.3 Rheumatoid nodule	0.000	0.994	0.006
M06.2 Rheumatoid bursitis	0.000	0.994	0.006
M06.1 Adult-onset Still's disease	0.000	0.994	0.006
E05 Thyrotoxicosis [hyperthyroidism]	0.006	0.994	0.000
E06.3 Autoimmune thyroiditis	0.006	0.994	0.000
E27 Other disorders of adrenal gland	0.006	0.994	0.000
E34.8 Other specified endocrine disorders	0.006	0.994	0.000
E53.1 Pyridoxine deficiency	0.006	0.994	0.000
E53.0 Riboflavin deficiency	0.006	0.994	0.000
E07 Other disorders of thyroid	0.006	0.994	0.000
I62.9 Intracranial haemorrhage (nontraumatic), unspecified	0.000	0.994	0.006
M06.34 Rheumatoid nodule (Hand)	0.000	0.994	0.006
E27.1 Primary adrenocortical insufficiency	0.006	0.994	0.000
E65-E68 Obesity and other hyperalimentation	0.006	0.994	0.000
E53.9 Vitamin B deficiency, unspecified	0.006	0.994	0.000
E15 Nondiabetic hypoglycaemic coma	0.006	0.994	0.000
I62 Other nontraumatic intracranial haemorrhage	0.000	0.994	0.006
M06.40 Inflammatory polyarthropathy (Multiple sites)	0.000	0.994	0.006
E29 Testicular dysfunction	0.006	0.994	0.000
M06.48 Inflammatory polyarthropathy (Other)	0.000	0.994	0.006
M06.47 Inflammatory polyarthropathy (Ankle and foot)	0.000	0.994	0.006
M06.46 Inflammatory polyarthropathy (Lower leg)	0.000	0.994	0.006
M06.45 Inflammatory polyarthropathy (Pelvic region and thigh)	0.000	0.994	0.006
M06.44 Inflammatory polyarthropathy (Hand)	0.000	0.994	0.006
M06.43 Inflammatory polyarthropathy (Forearm)	0.000	0.994	0.006
M06.42 Inflammatory polyarthropathy (Upper arm)	0.000	0.994	0.006
M06.41 Inflammatory polyarthropathy (Shoulder region)	0.000	0.994	0.006
E20.9 Hypoparathyroidism, unspecified	0.006	0.994	0.000
I77.8 Other specified disorders of arteries and arterioles	0.006	0.994	0.000
K50.8 Other Crohn's disease	0.000	0.994	0.006
E44.1 Mild protein-energy malnutrition	0.005	0.994	0.000
E44.0 Moderate protein-energy malnutrition	0.005	0.994	0.000
E35 Disorders of endocrine glands in diseases classified elsewhere	0.006	0.994	0.000
E32 Diseases of thymus	0.006	0.994	0.000
E30 Disorders of puberty, not elsewhere classified	0.006	0.994	0.000
M06.01 Seronegative rheumatoid arthritis (Shoulder region)	0.000	0.994	0.005
E25 Adrenogenital disorders	0.005	0.994	0.000
E26 Hyperaldosteronism	0.005	0.994	0.000
E23 Hypofunction and other disorders of pituitary gland	0.005	0.994	0.000
E31 Polyglandular dysfunction	0.005	0.995	0.000
E22 Hyperfunction of pituitary gland	0.005	0.995	0.000
M06.30 Rheumatoid nodule (Multiple sites)	0.000	0.995	0.005
E27.2 Addisonian crisis	0.005	0.995	0.000
E22.2 Syndrome of inappropriate secretion of antidiuretic hormone	0.005	0.995	0.000
E34.3 Short stature, not elsewhere classified	0.005	0.995	0.000
E55.0 Rickets, active	0.005	0.995	0.000
E05.2 Thyrotoxicosis with toxic multinodular goitre	0.005	0.995	0.000
E34.0 Carcinoid syndrome	0.005	0.995	0.000
W18.3 Sports and athletics area	0.005	0.995	0.000
M06.91 Rheumatoid arthritis, unspecified (Shoulder region)	0.000	0.995	0.005
M06.8 Other specified rheumatoid arthritis	0.000	0.995	0.005
E27.3 Drug-induced adrenocortical insufficiency	0.005	0.995	0.000
R82.6 Abnormal urine levels of substances chiefly nonmedicinal as to source	0.005	0.995	0.000
R82.3 Haemoglobinuria	0.005	0.995	0.000
R82.2 Biliuria	0.005	0.995	0.000
R82.0 Chyluria	0.005	0.995	0.000
E23.7 Disorder of pituitary gland, unspecified	0.005	0.995	0.000
R82.1 Myoglobinuria	0.005	0.995	0.000
E20.8 Other hypoparathyroidism	0.005	0.995	0.000
E20.1 Pseudohypoparathyroidism	0.005	0.995	0.000
E20.0 Idiopathic hypoparathyroidism	0.005	0.995	0.000
E34.5 Androgen resistance syndrome	0.005	0.995	0.000
E34.4 Constitutional tall stature	0.005	0.995	0.000
E34.2 Ectopic hormone secretion, not elsewhere classified	0.005	0.995	0.000
E34.1 Other hypersecretion of intestinal hormones	0.005	0.995	0.000
E05.9 Thyrotoxicosis, unspecified	0.005	0.995	0.000
M06.39 Rheumatoid nodule (Site unspecified)	0.000	0.995	0.005
M06.38 Rheumatoid nodule (Other)	0.000	0.995	0.005
M06.36 Rheumatoid nodule (Lower leg)	0.000	0.995	0.005
M06.35 Rheumatoid nodule (Pelvic region and thigh)	0.000	0.995	0.005
M06.31 Rheumatoid nodule (Shoulder region)	0.000	0.995	0.005
M06.98 Rheumatoid arthritis, unspecified (Other)	0.000	0.995	0.005
M06.19 Adult-onset Still's disease (Site unspecified)	0.000	0.995	0.005
M06.18 Adult-onset Still's disease (Other)	0.000	0.995	0.005
M06.17 Adult-onset Still's disease (Ankle and foot)	0.000	0.995	0.005
M06.16 Adult-onset Still's disease (Lower leg)	0.000	0.995	0.005
M06.15 Adult-onset Still's disease (Pelvic region and thigh)	0.000	0.995	0.005
M06.14 Adult-onset Still's disease (Hand)	0.000	0.995	0.005
M06.13 Adult-onset Still's disease (Forearm)	0.000	0.995	0.005
M06.12 Adult-onset Still's disease (Upper arm)	0.000	0.995	0.005
M06.11 Adult-onset Still's disease (Shoulder region)	0.000	0.995	0.005
M06.10 Adult-onset Still's disease (Multiple sites)	0.000	0.995	0.005
M06.29 Rheumatoid bursitis (Site unspecified)	0.000	0.995	0.005
M06.28 Rheumatoid bursitis (Other)	0.000	0.995	0.005
M06.27 Rheumatoid bursitis (Ankle and foot)	0.000	0.995	0.005
M06.26 Rheumatoid bursitis (Lower leg)	0.000	0.995	0.005
M06.25 Rheumatoid bursitis (Pelvic region and thigh)	0.000	0.995	0.005
M06.24 Rheumatoid bursitis (Hand)	0.000	0.995	0.005
M06.23 Rheumatoid bursitis (Forearm)	0.000	0.995	0.005
M06.22 Rheumatoid bursitis (Upper arm)	0.000	0.995	0.005
M06.21 Rheumatoid bursitis (Shoulder region)	0.000	0.995	0.005
M06.20 Rheumatoid bursitis (Multiple sites)	0.000	0.995	0.005
E05.5 Thyroid crisis or storm	0.005	0.995	0.000
E05.4 Thyrotoxicosis factitia	0.005	0.995	0.000
E05.3 Thyrotoxicosis from ectopic thyroid tissue	0.005	0.995	0.000
E27.5 Adrenomedullary hyperfunction	0.005	0.995	0.000
E27.0 Other adrenocortical overactivity	0.005	0.995	0.000
E05.1 Thyrotoxicosis with toxic single thyroid nodule	0.005	0.995	0.000
E27.8 Other specified disorders of adrenal gland	0.005	0.995	0.000
I62.1 Nontraumatic extradural haemorrhage	0.000	0.995	0.005
E07.1 Dyshormogenetic goitre	0.004	0.995	0.000
E07.0 Hypersecretion of calcitonin	0.004	0.995	0.000
R82.5 Elevated urine levels of drugs, medicaments and biological substances	0.005	0.995	0.000
E67 Other hyperalimentation	0.004	0.995	0.000
E68 Sequelae of hyperalimentation	0.004	0.995	0.000
E23.0 Hypopituitarism	0.005	0.995	0.000
E26.9 Hyperaldosteronism, unspecified	0.004	0.995	0.000
M06.33 Rheumatoid nodule (Forearm)	0.000	0.995	0.004
E29.9 Testicular dysfunction, unspecified	0.004	0.996	0.000
E29.8 Other testicular dysfunction	0.004	0.996	0.000
E29.0 Testicular hyperfunction	0.004	0.996	0.000
E29.1 Testicular hypofunction	0.004	0.996	0.000
E30.9 Disorder of puberty, unspecified	0.004	0.996	0.000
E30.8 Other disorders of puberty	0.004	0.996	0.000
E30.1 Precocious puberty	0.004	0.996	0.000
E30.0 Delayed puberty	0.004	0.996	0.000
E32.9 Disease of thymus, unspecified	0.004	0.996	0.000
E32.8 Other diseases of thymus	0.004	0.996	0.000
E32.1 Abscess of thymus	0.004	0.996	0.000
E32.0 Persistent hyperplasia of thymus	0.004	0.996	0.000
E35.8 Disorders of other endocrine glands in diseases classified elsewhere	0.004	0.996	0.000
E35.1 Disorders of adrenal glands in diseases classified elsewhere	0.004	0.996	0.000
E35.0 Disorders of thyroid gland in diseases classified elsewhere	0.004	0.996	0.000
E05.8 Other thyrotoxicosis	0.004	0.996	0.000
R82.7 Abnormal findings on microbiological examination of urine	0.004	0.996	0.000
T46 Poisoning by agents primarily affecting the cardiovascular system	0.004	0.996	0.000
E07.8 Other specified disorders of thyroid	0.004	0.996	0.000
M06.32 Rheumatoid nodule (Upper arm)	0.000	0.996	0.004
E25.9 Adrenogenital disorder, unspecified	0.004	0.996	0.000
E25.8 Other adrenogenital disorders	0.004	0.996	0.000
E23.3 Hypothalamic dysfunction, not elsewhere classified	0.004	0.996	0.000
E23.1 Drug-induced hypopituitarism	0.004	0.996	0.000
E26.8 Other hyperaldosteronism	0.004	0.996	0.000
E26.1 Secondary hyperaldosteronism	0.004	0.996	0.000
E31.9 Polyglandular dysfunction, unspecified	0.004	0.996	0.000
E31.8 Other polyglandular dysfunction	0.004	0.996	0.000
E31.1 Polyglandular hyperfunction	0.004	0.996	0.000
J86.9 Pyothorax without fistula	0.004	0.996	0.000
T46.4 Angiotensin-converting-enzyme inhibitors	0.004	0.996	0.000
E53.8 Deficiency of other specified B group vitamins	0.004	0.996	0.000
E22.8 Other hyperfunction of pituitary gland	0.004	0.996	0.000
O41.0 Oligohydramnios	0.004	0.996	0.000
E21 Hyperparathyroidism and other disorders of parathyroid gland	0.004	0.996	0.000
H59.8 Other postprocedural disorders of eye and adnexa	0.000	0.996	0.004
E28 Ovarian dysfunction	0.004	0.996	0.000
E25.0 Congenital adrenogenital disorders associated with enzyme deficiency	0.004	0.996	0.000
M06.88 Other specified rheumatoid arthritis (Other)	0.000	0.996	0.004
M06.87 Other specified rheumatoid arthritis (Ankle and foot)	0.000	0.996	0.004
M06.86 Other specified rheumatoid arthritis (Lower leg)	0.000	0.996	0.004
M06.85 Other specified rheumatoid arthritis (Pelvic region and thigh)	0.000	0.996	0.004
M06.84 Other specified rheumatoid arthritis (Hand)	0.000	0.996	0.004
M06.83 Other specified rheumatoid arthritis (Forearm)	0.000	0.996	0.004
M06.82 Other specified rheumatoid arthritis (Upper arm)	0.000	0.996	0.004
M06.81 Other specified rheumatoid arthritis (Shoulder region)	0.000	0.996	0.004
E31.0 Autoimmune polyglandular failure	0.004	0.996	0.000
D47.2 Monoclonal gammopathy	0.004	0.996	0.000
E24 Cushing's syndrome	0.004	0.996	0.000
E22.9 Hyperfunction of pituitary gland, unspecified	0.004	0.996	0.000
T46.1 Calcium-channel blockers	0.004	0.996	0.000
M06.94 Rheumatoid arthritis, unspecified (Hand)	0.000	0.996	0.004
I77 Other disorders of arteries and arterioles	0.004	0.996	0.000
T50.9 Other and unspecified drugs, medicaments and biological substances	0.004	0.996	0.000
E65 Localised adiposity	0.004	0.996	0.000
M06.93 Rheumatoid arthritis, unspecified (Forearm)	0.000	0.996	0.003
E23.6 Other disorders of pituitary gland	0.004	0.996	0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.004	0.996	0.000
D47.3 Essential (haemorrhagic) thrombocythaemia	0.004	0.996	0.000
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.004	0.996	0.000
M79.69 Pain in limb (Site unspecified)	0.000	0.996	0.004
E21.1 Secondary hyperparathyroidism, not elsewhere classified	0.004	0.996	0.000
I47.2 Ventricular tachycardia	0.000	0.996	0.004
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.004	0.996	0.000
I77.6 Arteritis, unspecified	0.004	0.996	0.000
C18.9 Colon, unspecified	0.004	0.996	0.000
E67.8 Other specified hyperalimentation	0.003	0.996	0.000
E67.3 Hypervitaminosis D	0.003	0.996	0.000
E67.2 Megavitamin-B6 syndrome	0.003	0.996	0.000
E67.1 Hypercarotenaemia	0.003	0.996	0.000
E67.0 Hypervitaminosis A	0.003	0.996	0.000
M06.89 Other specified rheumatoid arthritis (Site unspecified)	0.000	0.996	0.003
E26.0 Primary hyperaldosteronism	0.003	0.996	0.000
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.003	0.996	0.000
I83.1 Varicose veins of lower extremities with inflammation	0.000	0.996	0.004
W18 Other fall on same level	0.004	0.996	0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.003	0.997	0.000
M06.80 Other specified rheumatoid arthritis (Multiple sites)	0.000	0.997	0.003
W18.1 Residential institution	0.003	0.997	0.000
M06.37 Rheumatoid nodule (Ankle and foot)	0.000	0.997	0.003
T46.3 Coronary vasodilators, not elsewhere classified	0.003	0.997	0.000
T36-T50 Poisoning by drugs, medicaments and biological substances	0.003	0.997	0.000
E21.4 Other specified disorders of parathyroid gland	0.003	0.997	0.000
E21.0 Primary hyperparathyroidism	0.003	0.997	0.000
T46.8 Antivaricose drugs, including sclerosing agents	0.003	0.997	0.000
T46.7 Peripheral vasodilators	0.003	0.997	0.000
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.003	0.997	0.000
D47 Other neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue	0.003	0.997	0.000
E22.0 Acromegaly and pituitary gigantism	0.003	0.997	0.000
I77.3 Arterial fibromuscular dysplasia	0.003	0.997	0.000
S02.40 Fracture of malar and maxillary bones (closed)	0.003	0.997	0.000
I77.0 Arteriovenous fistula, acquired	0.003	0.997	0.000
L03.2 Cellulitis of face	0.003	0.997	0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.003	0.997	0.000
E28.9 Ovarian dysfunction, unspecified	0.003	0.997	0.000
E28.8 Other ovarian dysfunction	0.003	0.997	0.000
E28.1 Androgen excess	0.003	0.997	0.000
E28.0 Oestrogen excess	0.003	0.997	0.000
T47.1 Other antacids and anti-gastric-secretion drugs	0.003	0.997	0.000
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.003	0.997	0.000
O30.0 Twin pregnancy	0.000	0.997	0.003
T50.8 Diagnostic agents	0.003	0.997	0.000
E24.4 Alcohol-induced pseudo-Cushing's syndrome	0.003	0.997	0.000
E24.3 Ectopic ACTH syndrome	0.003	0.997	0.000
E24.1 Nelson's syndrome	0.003	0.997	0.000
D47.7 Other specified neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue	0.003	0.997	0.000
E27.4 Other and unspecified adrenocortical insufficiency	0.003	0.997	0.000
I77.9 Disorder of arteries and arterioles, unspecified	0.003	0.997	0.000
K80.0 Calculus of gallbladder with acute cholecystitis	0.003	0.997	0.000
T50.6 Antidotes and chelating agents, not elsewhere classified	0.003	0.997	0.000
I77.5 Necrosis of artery	0.003	0.997	0.000
I77.4 Coeliac artery compression syndrome	0.003	0.997	0.000
E16 Other disorders of pancreatic internal secretion	0.003	0.997	0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.003	0.997	0.000
D47.9 Neoplasm of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue, unspecified	0.003	0.997	0.000
I77.2 Rupture of artery	0.003	0.997	0.000
T47.6 Antidiarrhoeal drugs	0.003	0.997	0.000
T50.1 Loop [high-ceiling] diuretics	0.003	0.997	0.000
K50.0 Crohn's disease of small intestine	0.000	0.997	0.003
T50.7 Analeptics and opioid receptor antagonists	0.003	0.997	0.000
T50.5 Appetite depressants	0.003	0.997	0.000
T50.3 Electrolytic, caloric and water-balance agents	0.003	0.997	0.000
T50.0 Mineralocorticoids and their antagonists	0.003	0.997	0.000
W18.5 Trade and service area	0.003	0.997	0.000
E21.2 Other hyperparathyroidism	0.003	0.997	0.000
E24.8 Other Cushing's syndrome	0.003	0.997	0.000
E24.0 Pituitary-dependent Cushing's disease	0.003	0.997	0.000
R16.0 Hepatomegaly, not elsewhere classified	0.003	0.997	0.000
T47.2 Stimulant laxatives	0.003	0.997	0.000
E22.1 Hyperprolactinaemia	0.003	0.997	0.000
T47.4 Other laxatives	0.003	0.997	0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.003	0.997	0.000
T46.5 Other antihypertensive drugs, not elsewhere classified	0.003	0.997	0.000
D47.4 Osteomyelofibrosis	0.003	0.997	0.000
D47.0 Histiocytic and mast cell tumours of uncertain and unknown behaviour	0.003	0.997	0.000
E21.5 Disorder of parathyroid gland, unspecified	0.003	0.997	0.000
S61.9 Open wound of wrist and hand, part unspecified	0.000	0.997	0.003
E27.9 Disorder of adrenal gland, unspecified	0.002	0.997	0.000
T38.0 Glucocorticoids and synthetic analogues	0.003	0.997	0.000
H25.9 Senile cataract, unspecified	0.000	0.997	0.003
K27.9 Unspecified as acute or chronic, without haemorrhage or perforation	0.003	0.997	0.000
W18.9 Unspecified place	0.003	0.997	0.000
W18.8 Other specified place	0.003	0.997	0.000
W18.4 Street and highway	0.003	0.997	0.000
W18.2 School, other institution and public administrative area	0.003	0.997	0.000
W18.0 Home	0.003	0.997	0.000
W18.7 Farm	0.003	0.997	0.000
W18.6 Industrial and construction area	0.003	0.997	0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.003	0.997	0.000
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.003	0.997	0.000
T47.8 Other agents primarily affecting the gastro-intestinal system	0.003	0.997	0.000
T47.7 Emetics	0.003	0.997	0.000
T47.5 Digestants	0.003	0.997	0.000
T47.3 Saline and osmotic laxatives	0.003	0.997	0.000
T47.0 Histamine H(2)-receptor antagonists	0.003	0.997	0.000
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.003	0.997	0.000
T38.5 Other oestrogens and progestogens	0.003	0.997	0.000
T45.0 Antiallergic and antiemetic drugs	0.003	0.997	0.000
T41 Poisoning by anaesthetics and therapeutic gases	0.003	0.997	0.000
E24.2 Drug-induced Cushing's syndrome	0.002	0.997	0.000
E34.9 Endocrine disorder, unspecified	0.002	0.997	0.001
T38.1 Thyroid hormones and substitutes	0.003	0.997	0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.003	0.997	0.000
D47.5 Chronic eosinophilic leukaemia [hypereosinophilic syndrome]	0.003	0.997	0.000
E28.3 Primary ovarian failure	0.002	0.997	0.000
T50.4 Drugs affecting uric acid metabolism	0.003	0.997	0.000
T37.8 Other specified systemic anti-infectives and antiparasitics	0.003	0.997	0.000
O75.8 Other specified complications of labour and delivery	0.003	0.997	0.000
D86.9 Sarcoidosis, unspecified	0.003	0.997	0.000
E23.2 Diabetes insipidus	0.002	0.997	0.000
R84.5 Abnormal microbiological findings	0.000	0.997	0.003
T51 Toxic effect of alcohol	0.003	0.997	0.000
E24.9 Cushing's syndrome, unspecified	0.002	0.997	0.000
T38.9 Other and unspecified hormone antagonists	0.002	0.997	0.000
T38.8 Other and unspecified hormones and their synthetic substitutes	0.002	0.997	0.000
T38.7 Androgens and anabolic congeners	0.002	0.997	0.000
T38.4 Oral contraceptives	0.002	0.997	0.000
T38.2 Antithyroid drugs	0.002	0.997	0.000
T37.2 Antimalarials and drugs acting on other blood protozoa	0.002	0.997	0.000
T45.1 Antineoplastic and immunosuppressive drugs	0.002	0.997	0.000
K50 Crohn's disease [regional enteritis]	0.000	0.997	0.003
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.002	0.997	0.000
O75.7 Vaginal delivery following previous Caesarean section	0.002	0.998	0.000
E16.9 Disorder of pancreatic internal secretion, unspecified	0.002	0.998	0.000
E16.8 Other specified disorders of pancreatic internal secretion	0.002	0.998	0.000
E16.4 Abnormal secretion of gastrin	0.002	0.998	0.000
E16.3 Increased secretion of glucagon	0.002	0.998	0.000
T40.3 Methadone	0.002	0.998	0.000
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.002	0.998	0.000
H59 Postprocedural disorders of eye and adnexa, not elsewhere classified	0.000	0.998	0.002
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.002	0.998	0.000
T36 Poisoning by systemic antibiotics	0.002	0.998	0.000
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.002	0.998	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations